Style | Citing Format |
---|---|
MLA | Farhangnia P, et al.. "Recent Advances in Passive Immunotherapies for Covid-19: The Evidence-Based Approaches and Clinical Trials." International Immunopharmacology, vol. 109, no. , 2022, pp. -. |
APA | Farhangnia P, Dehrouyeh S, Safdarian AR, Farahani SV, Gorgani M, Rezaei N, Akbarpour M, Delbandi AA (2022). Recent Advances in Passive Immunotherapies for Covid-19: The Evidence-Based Approaches and Clinical Trials. International Immunopharmacology, 109(), -. |
Chicago | Farhangnia P, Dehrouyeh S, Safdarian AR, Farahani SV, Gorgani M, Rezaei N, Akbarpour M, Delbandi AA. "Recent Advances in Passive Immunotherapies for Covid-19: The Evidence-Based Approaches and Clinical Trials." International Immunopharmacology 109, no. (2022): -. |
Harvard | Farhangnia P et al. (2022) 'Recent Advances in Passive Immunotherapies for Covid-19: The Evidence-Based Approaches and Clinical Trials', International Immunopharmacology, 109(), pp. -. |
Vancouver | Farhangnia P, Dehrouyeh S, Safdarian AR, Farahani SV, Gorgani M, Rezaei N, et al.. Recent Advances in Passive Immunotherapies for Covid-19: The Evidence-Based Approaches and Clinical Trials. International Immunopharmacology. 2022;109():-. |
BibTex | @article{ author = {Farhangnia P and Dehrouyeh S and Safdarian AR and Farahani SV and Gorgani M and Rezaei N and Akbarpour M and Delbandi AA}, title = {Recent Advances in Passive Immunotherapies for Covid-19: The Evidence-Based Approaches and Clinical Trials}, journal = {International Immunopharmacology}, volume = {109}, number = {}, pages = {-}, year = {2022} } |
RIS | TY - JOUR AU - Farhangnia P AU - Dehrouyeh S AU - Safdarian AR AU - Farahani SV AU - Gorgani M AU - Rezaei N AU - Akbarpour M AU - Delbandi AA TI - Recent Advances in Passive Immunotherapies for Covid-19: The Evidence-Based Approaches and Clinical Trials JO - International Immunopharmacology VL - 109 IS - SP - EP - PY - 2022 ER - |